PIRFENIDONE
Active substance: pirfenidone
CAPSULE · PIRFENIDONE 267 mg/1
United StatesActive
Marketing holder: ScieGen Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PIRFENIDONE · 267 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 3 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2af5-78ca-9b1e-17fc9af10999,01a1208c-3f80-77b6-af82-56f6a5ad6e63,01a1208c-59f0-7c0e-ac0d-ebe80629a5fb,01a1208d-248c-745b-8261-e576b69453a2,01a1208d-6017-7475-bcbc-09ed1f2cfe40;count=61 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50228-441
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 50228-441 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50228-441 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50228-441 · Verified 2026-10-09 · open in source